17-octadecynoic acid has been researched along with 8,11,14-eicosatrienoic acid in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imig, JD; Ortiz de Montellano, PR; Roman, RJ; Sui, Z; Zou, AP | 1 |
| Falcone, JC; Grider, JS; Jackson, BA; Kilpatrick, EL; Ott, CE | 1 |
| Chataigneau, T; Duhault, J; Félétou, M; Vanhoutte, PM | 1 |
| Ivey, CL; Stephenson, AH; Townsley, MI | 1 |
| Brand-Schieber, E; Falck, JF; Schwartzman, M | 1 |
| Earley, S; Pastuszyn, A; Walker, BR | 1 |
| Campbell, WB; Endsley, MP; Falck, JR; Gross, ER; Gross, GJ; Isbell, MA; Moore, JM; Nithipatikom, K | 1 |
| Chen, R; Jiang, J; Wang, D; Xiao, X | 1 |
| Gebremedhin, D; Harder, DR; Jakovcevic, D; Zagorac, D | 1 |
| Chen, Z; Jiang, J; Li, Q; Liu, F; Shao, J; Wang, H; Zhu, X; Zou, P | 1 |
10 other study(ies) available for 17-octadecynoic acid and 8,11,14-eicosatrienoic acid
| Article | Year |
|---|---|
Cytochrome P-450 inhibitors alter afferent arteriolar responses to elevations in pressure.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Arterioles; Cytochrome P-450 Enzyme Inhibitors; Fatty Acids, Unsaturated; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Kidney; Kidney Cortex; Miconazole; Microsomes; Muscle, Smooth, Vascular; Oxazines; Perfusion; Rats; Rats, Sprague-Dawley; Renal Circulation | 1994 |
P450 arachidonate metabolites mediate bradykinin-dependent inhibition of NaCl transport in the rat thick ascending limb.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Bradykinin; Calcium; Cyclic GMP; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Fatty Acids, Unsaturated; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Kidney Tubules, Distal; Male; Rats; Rats, Sprague-Dawley; Sodium Chloride | 1997 |
Epoxyeicosatrienoic acids, potassium channel blockers and endothelium-dependent hyperpolarization in the guinea-pig carotid artery.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Carotid Arteries; Charybdotoxin; Cytochrome P-450 Enzyme Inhibitors; Electromyography; Endothelium, Vascular; Enzyme Inhibitors; Fatty Acids, Unsaturated; Guinea Pigs; Male; Membrane Potentials; Peptides; Potassium Channel Blockers | 1998 |
Involvement of cytochrome P-450 enzyme activity in the control of microvascular permeability in canine lung.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Capillary Permeability; Clotrimazole; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dogs; Endothelium, Vascular; Fatty Acids, Unsaturated; In Vitro Techniques; Lung; Microcirculation; Potassium Channels; Pulmonary Circulation; Tetraethylammonium; Thapsigargin | 1998 |
Selective inhibition of arachidonic acid epoxidation in vivo.
Topics: 8,11,14-Eicosatrienoic Acid; Amides; Animals; Arachidonic Acid; Chromatography, High Pressure Liquid; Cyclodextrins; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acids, Unsaturated; Humans; Immunoblotting; Kidney; Male; Miconazole; Microsomes; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Sulfones | 2000 |
Cytochrome p-450 epoxygenase products contribute to attenuated vasoconstriction after chronic hypoxia.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Calcium Channel Blockers; Cell Membrane; Chronic Disease; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Fatty Acids, Unsaturated; Hypoxia; In Vitro Techniques; Male; Membrane Potentials; Mesenteric Arteries; Muscle, Smooth, Vascular; Oxygenases; Potassium Channels, Calcium-Activated; Proadifen; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Vasoconstriction | 2003 |
Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway.
Topics: 8,11,14-Eicosatrienoic Acid; Amides; Animals; Arachidonic Acids; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dogs; Fatty Acids, Unsaturated; Female; Hydroxyeicosatetraenoic Acids; Isoenzymes; Male; Miconazole; Microsomes; Mixed Function Oxygenases; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Sulfones | 2004 |
Effects of epoxyeicosatrienoic acids on levels of eNOS phosphorylation and relevant signaling transduction pathways involved.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Aryl Hydrocarbon Hydroxylases; Cattle; Cells, Cultured; Cytochrome P450 Family 2; Endothelial Cells; Endothelium, Vascular; Fatty Acids, Unsaturated; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Steroid 16-alpha-Hydroxylase; Up-Regulation | 2005 |
Antiangiogenic effect of inhibitors of cytochrome P450 on rats with glioblastoma multiforme.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Antifungal Agents; Antineoplastic Agents; Arachidonic Acid; Aryl Hydrocarbon Hydroxylases; Astrocytes; Cytochrome P450 Family 2; Enzyme Inhibitors; Fatty Acids, Unsaturated; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glioblastoma; Male; Miconazole; Neoplasm Proteins; Neovascularization, Pathologic; Rats; Rats, Inbred F344; Steroid 16-alpha-Hydroxylase | 2008 |
P-450-dependent epoxygenase pathway of arachidonic acid is involved in myeloma-induced angiogenesis of endothelial cells.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acids; Bone Marrow Neoplasms; Cell Line; Cell Line, Tumor; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Endothelial Cells; Fatty Acids, Unsaturated; Humans; Mice; Mice, Inbred C57BL; Multiple Myeloma; Neovascularization, Pathologic | 2011 |